Contact

All Stories

  1. Therapeutic Monoclonal Antibodies against Cancer: Present and Future

    Article • Cells, December 2023, MDPI AG

    Dr Jose A. Garcia-Sanz

  2. Stemming Tumoral Growth: A Matter of Grotesque Organogenesis

    Article • Cells, March 2023, MDPI AG

    Dr Jose A. Garcia-Sanz

  3. Editorial: The effects of chemotherapy towards the tumor microenvironment

    Article • Frontiers in Oncology, November 2022, Frontiers

    Dr Jose A. Garcia-Sanz

  4. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors

    Article • Frontiers in Immunology, July 2022, Frontiers

    Dr Jose A. Garcia-Sanz

  5. Cell Therapy Based on Gingiva-Derived Mesenchymal Stem Cells Seeded in a Xenogeneic Collagen Matrix for Root Coverage of RT1 Gingival Lesions: An In Vivo Experimental Study

    Article • International Journal of Molecular Sciences, March 2022, MDPI AG

    Dr Jose A. Garcia-Sanz

  6. Periodontal regeneration using a xenogeneic bone substitute seeded with autologous periodontal ligament‐derived mesenchymal stem cells: A 12‐month quasi‐randomized controlled pilot clinical trial

    Article • Journal Of Clinical Periodontology, October 2020, Wiley

    Dr Jose A. Garcia-Sanz

  7. 11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells

    Article • Scientific Reports, August 2019, Springer Science + Business Media

    Dr Jose A. Garcia-Sanz

  8. Sfrp3 modulates stromal–epithelial crosstalk during mammary gland development by regulating Wnt levels

    Article • Nature Communications, June 2019, Springer Science + Business Media

    Dr Jose A. Garcia-Sanz

  9. Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?

    Article • Frontiers in Immunology, March 2018, Frontiers

    Dr Jose A. Garcia-Sanz

  10. 92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts

    Article • Frontiers in Immunology, January 2018, Frontiers

    Dr Jose A. Garcia-Sanz

  11. Cell therapy with allogenic canine periodontal ligament‐derived cells in periodontal regeneration of critical size defects

    Article • Journal Of Clinical Periodontology, January 2018, Wiley

    Dr Jose A. Garcia-Sanz

  12. Is the Recent Burst of Therapeutic Anti-Tumor Antibodies the Tip of an Iceberg?

    Article • January 2018, Frontiers

    Dr Jose A. Garcia-Sanz

  13. New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness

    Article • Frontiers in Immunology, December 2017, Frontiers

    Dr Jose A. Garcia-Sanz

  14. Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?

    Article • Frontiers in Immunology, November 2017, Frontiers

    Dr Jose A. Garcia-Sanz

  15. Comparison of periodontal ligament and gingiva-derived mesenchymal stem cells for regenerative therapies

    Article • Clinical Oral Investigations, June 2016, Springer Science + Business Media

    Dr Jose A. Garcia-Sanz

  16. Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges

    Article • Frontiers in Immunology, January 2015, Frontiers

    Dr Jose A. Garcia-Sanz

  17. Detection of mouse endogenous type B astrocytes migrating towards brain lesions

    Article • Stem Cell Research, January 2015, Elsevier

    Dr Jose A. Garcia-Sanz

  18. Insights of the brain damage response using antibodies identifying surface antigens on neural stem cells and neuroblasts

    Article • Neural Regeneration Research, January 2015, Medknow

    Dr Jose A. Garcia-Sanz

  19. Activation of RANKL-induced osteoclasts and memory T lymphocytes byPorphyromonas gingivalisis serotype dependant

    Article • Journal Of Clinical Periodontology, April 2014, Wiley

    Dr Jose A. Garcia-Sanz

  20. Distinct human T-lymphocyte responses triggered byPorphyromonas gingivaliscapsular serotypes

    Article • Journal Of Clinical Periodontology, November 2013, Wiley

    Dr Jose A. Garcia-Sanz

  21. Live Imaging of Mouse Endogenous Neural Progenitors Migrating in Response to an Induced Tumor

    Article • PLoS ONE, September 2012, PLOS

    Dr Jose A. Garcia-Sanz

  22. Hormones control the number of mammary stem cells and therefore epithelial tree size

    Article • The FASEB Journal, June 2012, Wiley

    Dr Jose A. Garcia-Sanz

  23. Targeting Neural Stem Cells with Titanium Dioxide Nanoparticles Coupled to Specific Monoclonal Antibodies

    Article • Journal of Biomaterials Applications, May 2011, SAGE Publications

    Dr Jose A. Garcia-Sanz

  24. Characterization of novel monoclonal antibodies able to identify neurogenic niches and arrest neurosphere proliferation and differentiation

    Article • Neuroscience, September 2010, Elsevier

    Dr Jose A. Garcia-Sanz

  25. Differential cytokine expression by human dendritic cells in response to differentPorphyromonas gingivaliscapsular serotypes

    Article • Journal Of Clinical Periodontology, October 2009, Wiley

    Dr Jose A. Garcia-Sanz

  26. Editorial [Hot Topic: New Strategies and Tools to Identify Drug Targets on Infectious Disorders(Guest Editor: Jose A. Garcia-Sanz)]

    Article • Infectious Disorders - Drug Targets, December 2008, Bentham Science Publishers

    Dr Jose A. Garcia-Sanz

  27. Variability in the response of human dendritic cells stimulated withPorphyromonas gingivalisorAggregatibacter actinomycetemcomitans

    Article • Journal of Periodontal Research, December 2008, Wiley

    Dr Jose A. Garcia-Sanz

  28. Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection

    Article • Infectious Disorders - Drug Targets, December 2008, Bentham Science Publishers

    Dr Jose A. Garcia-Sanz

  29. Translation Controlled mRNAs: New Drug Targets in Infectious Diseases?

    Article • Infectious Disorders - Drug Targets, December 2008, Bentham Science Publishers

    Dr Jose A. Garcia-Sanz

  30. Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint

    Article • Archives of Oral Biology, October 2008, Elsevier

    Dr Jose A. Garcia-Sanz

  31. Variabilidad de la Respuesta de las Células Dendríticas Estimuladas in vitro con Porphyromonas gingivalis y Aggregatibacter actinomycetemcomitans

    Article • Revista clínica de periodoncia implantología y rehabilitación oral, April 2008, Elsevier

    Dr Jose A. Garcia-Sanz

  32. CCL2 Inhibits the Apoptosis Program Induced by Growth Factor Deprivation, Rescuing Functional T Cells

    Article • The Journal of Immunology, November 2007, The American Association of Immunologists

    Dr Jose A. Garcia-Sanz

  33. An adaptation of the LMS method to determine expression variations in profiling data

    Article • Nucleic Acids Research, April 2007, Oxford University Press (OUP)

    Dr Jose A. Garcia-Sanz

  34. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments

    Article • RNA, February 2007, Cold Spring Harbor Laboratory Press

    Dr Jose A. Garcia-Sanz

  35. Phosphoinositide 3-Kinase Activation Regulates Cell Division Time by Coordinated Control of Cell Mass and Cell Cycle Progression Rate

    Article • Journal of Biological Chemistry, April 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Jose A. Garcia-Sanz

  36. T Cell Activation In Vivo Targets Diacylglycerol Kinase   to the Membrane: A Novel Mechanism for Ras Attenuation

    Article • The Journal of Immunology, March 2003, The American Association of Immunologists

    Dr Jose A. Garcia-Sanz

  37. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein

    Article • The EMBO Journal, November 2002, Wiley

    Dr Jose A. Garcia-Sanz

  38. Degradation of cellular mRNA is a general early apoptosis‐induced event

    Article • The FASEB Journal, October 2002, Wiley

    Dr Jose A. Garcia-Sanz

  39. Regulation of mRNA Expression in Macrophages after Yersinia enterocolitica Infection. ROLE OF DIFFERENT Yop EFFECTORS

    Article • Journal of Biological Chemistry, May 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Jose A. Garcia-Sanz

  40. Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics

    Article • Journal of Biological Chemistry, April 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Jose A. Garcia-Sanz

  41. Translation control: bridging the gap between genomics and proteomics?

    Article • Trends in Biochemical Sciences, April 2001, Elsevier

    Dr Jose A. Garcia-Sanz

  42. Isolation of translationally controlled mRNAs by differential screening

    Article • The FASEB Journal, August 2000, Wiley

    Dr Jose A. Garcia-Sanz

  43. Structure and Function of the Iron-Responsive Element from Human Ferritin L Chain mRNA

    Article • Biochemical and Biophysical Research Communications, June 1997, Elsevier

    Dr Jose A. Garcia-Sanz

  44. Transcriptional and translational control of TNF-α gene expression in human monocytes by major histocompatibility complex class II ligands

    Article • European Journal of Immunology, October 1996, Wiley

    Dr Jose A. Garcia-Sanz

  45. Translational control of interleukin 2 messenger RNA as a molecular mechanism of T cell anergy

    Article • The Journal of Experimental Medicine, July 1996, Rockefeller University Press

    Dr Jose A. Garcia-Sanz

  46. CTX, a novel molecule specifically expressed on the surface of cortical thymocytes inXenopus

    Article • European Journal of Immunology, April 1996, Wiley

    Dr Jose A. Garcia-Sanz, Dr Jacques Robert

  47. Preparation of RNA

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  48. Polysome gradients

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  49. Outlook

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  50. Recommended reading

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  51. Introduction and historical background

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  52. Analysis of RNA expression by Northern blotting

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  53. RNAase protection and primer extension

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  54. Run-on assays

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  55. Analysis of mRNA decay

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  56. Additional uses of RNA probes

    Article • January 1996, Elsevier

    Dr Jose A. Garcia-Sanz

  57. Regulation of perforin gene expression in a T cell hybrid with inducible cytolytic activity

    Article • European Journal of Immunology, August 1993, Wiley

    Dr Jose A. Garcia-Sanz

  58. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells

    Article • Science, June 1993, American Association for the Advancement of Science

    Dr Jose A. Garcia-Sanz

  59. The mouse male germ cell-specific gene Tpx-1: molecular structure, mode of expression in spermatogenesis, and sequence similarity to two non-mammalian genes

    Article • Mammalian Genome, January 1992, Springer Science + Business Media

    Dr Jose A. Garcia-Sanz

  60. Cell specificity of granzyme gene expression.

    Article • The Journal of Immunology, November 1990, The American Association of Immunologists

    Dr Jose A. Garcia-Sanz

  61. Analysis of the Cellular Parameters of the Immune Responses contributing to Resistance and Susceptibility of Mice to Infection with the Intracellular Parasite, Leishmania major

    Article • Immunological Reviews, December 1989, Wiley

    Dr Jose A. Garcia-Sanz

  62. Perforin is present only in normal activated Lyt2+ T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets.

    Article • The EMBO Journal, April 1987, Wiley

    Dr Jose A. Garcia-Sanz